Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and Hepatitis C Virus Genotype 3 Infection in HIV-Seropositive Patients

Background. We conducted a study to determine the prevalence and factors associated with hepatic steatosis in human immunodeficiency virus (HIV)—seropositive patients with hepatitis C and to investigate whether steatosis is associated with liver fibrosis. Methods. Retrospective chart reviews were co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2006-08, Vol.43 (3), p.365-372
Hauptverfasser:	McGovern, Barbara H., Ditelberg, Jeremy S., Taylor, Lynn E., Gandhi, Rajesh T., Christopoulos, Katerina A., Chapman, Stacey, Schwartzapfel, Beth, Rindler, Emily, Fiorino, Anne-Marie, Zaman, M. Tauheed, Sax, Paul E., Graeme-Cook, Fiona, Hibberd, Patricia L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - adverse effects Antiretrovirals Biopsies Comorbidity Cystic fibrosis Fatty Liver - etiology Fatty Liver - pathology Female Fibrosis Genotype Genotypes Hepacivirus Hepatitis Hepatitis C Hepatitis C - classification Hepatitis C - epidemiology Hepatitis C virus HIV HIV Seropositivity - epidemiology HIV/AIDS Human immunodeficiency virus Humans Infections Liver Liver Cirrhosis - etiology Liver Cirrhosis - pathology Male Middle Aged Nucleosides Nucleosides - adverse effects Oxidative stress Pathology Prevalence Retrospective Studies Reverse Transcriptase Inhibitors - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!